INTRODUCTION
============

Sterols are important components of membranes in most eukaryotic organisms, although their structures differ among plants, fungi, and mammals. It seems that sterols interact functionally with sphingolipids, and it has been postulated that the two lipid species could have coevolved to ensure their function in the different kingdoms, which also have distinct types of sphingolipids ([@B25]; [@B27]). Interestingly, the biosynthetic pathways for sterol biosynthesis show differences between the plant and animal kingdoms ([@B60]) and strategies for sterol supply also differ greatly among the kingdoms. Plants and fungi synthesize their required sterols, whereas humans regulate their cholesterol levels through a combination of cholesterol uptake/redistribution and de novo synthesis ([@B23]). Insects and worms have another strategy. They take up and use sterols but do not synthesize them de novo ([@B39]; [@B4]). Therefore regulation of sterol levels is likely to differ considerably among different organisms.

Sterol function is critical for humans, as diseases in cholesterol biosynthesis cause hereditary disorders ([@B33]; [@B50]) and defects in cholesterol/low density lipoprotein trafficking has been linked to atherosclerosis ([@B22]). Ergosterol biosynthesis in fungi is also a prime target for antifungals. While sterols perform essential functions, due to their effects on the physical properties of membranes and their insolubility in an aqueous environment, the amount of free sterols has to be tightly regulated. Elevated cholesterol levels correlate with incidence of cardiovascular disease ([@B23]). In animals, cholesterol is taken up by endocytosis and delivered to the cytoplasm. Sterols are delivered to the endoplasmic reticulum (ER), where they can be converted to cholesterol esters and stored in lipid droplets, whereas the level of free cholesterol in the ER regulates de novo cholesterol and other lipid synthetic pathways via control of gene expression. The components of this regulatory mechanism include the proteins INSIG, SCAP, and SREBP. The cholesterol-dependent association of INSIG with SCAP is essential for the regulation ([@B53]). The regulatory mechanism is conserved in mammals but not completely in fungi. In *Schizosaccaromyces pombe*, the SCAP (scp1) and SREBP (sre1) homologues are regulated by oxygen levels rather than sterols ([@B30]). This points to an evolutionary connection between oxygen sensing and sterol biosynthesis ([@B16]). This is, in some respects, logical because the conversion of squalene to squalene epoxide in sterol biosynthesis requires O~2~.

*Saccharomyces cerevisiae* does not have homologues of these regulatory proteins, so the control of ergosterol biosynthesis is regulated differently. Nevertheless, oxygen status and regulation of sterol biosynthesis are somehow related. Under anaerobic conditions where they cannot synthesize ergosterol, *S. cerevisiae* cells express a set of genes, the so-called anaerobic genes, some of which facilitate sterol uptake from the media ([@B1]). Other perturbations, such as drug treatments that reduce sterol levels, induce sterol biosynthesis genes, and this regulation depends on a sterol response element that is identical to the anaerobic response element ([@B18]). Therefore the promoters of the anaerobically expressed genes and sterol synthesis genes share common regulatory elements. This raises an interesting question: how can similar elements give differential regulation?

Under normal growth conditions sterol biosynthesis genes are expressed, whereas anaerobic genes are not. However, transcriptome data from mutants in ergosterol biosynthesis showed that ergosterol biosynthesis genes and anaerobic genes were coinduced in sterol mutants ([@B25]). This suggests that sterols regulate both sets of genes. Indeed, the transcription factor Upc2p binds to the sterol response element ([@B18]) and is implicated in expression of both anaerobic and sterol biosynthetic genes. Upc2p binds ergosterol through its C-terminal domain, and when this site is unoccupied, Upc2p shuttles to the nucleus, where it can induce transcription ([@B63]). However, Upc2p alone cannot explain how these two sets of genes are oppositely regulated under aerobic conditions and coordinately regulated in sterol mutants. It could be by a negative regulation of anaerobic genes under aerobic conditions or a coactivator requirement. The negative regulatory mechanism is still unclear, although it also requires the sterol response element ([@B1]) and no coactivator of Upc2p-dependent transcription has been identified ([@B63]).

Here we investigated the mechanism whereby sterol synthesis and anaerobic genes are coordinately regulated in sterol mutants. We tested a number of candidate transcription factors, including Upc2p, but none of them could fully account for the coordinate regulation. Using a genetic selection, we identified mutations in two important subunits of the evolutionarily conserved SAGA complex, *HFI1* and *SPT7*. Mutations in the SAGA complex are unable to coordinately induce these two sets of genes, as well as other sets of genes that are induced in the ergosterol mutants, such as stress response proteins and basic amino acid biosynthesis. ChIP-Seq analysis showed that in an *erg3* mutant the SAGA complex was enriched on promoters of ergosterol synthesis and anaerobic genes. Proteomics of purified SAGA complexes from an *erg3* mutant showed a differential enrichment of several transcription factors including Upc2p, Hap1, Skn7, and Pdr1, components of the SWI/SNF chromatin remodeling complex, and unexpectedly, the endocytic protein Rvs167p. Our results show that the SAGA complex plays an important role in the reprofiling of gene expression due to changes in sterol composition and our data are consistent with its role as coactivator for several different transcription factors. Coisolation of Rvs167p with the SAGA complex in the *erg3* mutant and the effect of the *rvs167* mutation on induction of two heat shock proteins in the *erg3* mutant provide evidence for a moonlighting function in transcription for this endocytic protein.

RESULTS
=======

Previously, using transcript microarray analysis, we showed that a series of mutants in ergosterol biosynthesis coordinately up-regulated the mRNA levels of genes involved in ergosterol biosynthesis as well as anaerobic growth ([@B25]). In addition, coordinate regulation of genes involved in other processes, such as ribosome biogenesis, sphingolipid degradation, basic amino acid synthesis, phosphate metabolism, and stress, was seen. The transcript profiles of the *erg2*, *erg3* and *erg6* mutants were very similar, so we chose to work with the *erg3* mutant for this study because it grows better than the other two mutant strains. First, we confirmed the microarray findings for the ergosterol and anaerobic genes by real-time PCR using the wild-type and *erg3* mutant strains (Supplemental Table 1).

Requirement of the SAGA complex
-------------------------------

To identify genes that are required for the coordinate regulation of these two sets of genes, a selection scheme was developed. The open reading frame (ORF) and 3′ end of *URA3* was placed downstream of the *DAN1* promoter, which is normally expressed only under anaerobic conditions, placing expression of Ura3p under control of an anaerobic promoter. Ura3p expression permits a positive and negative selection in a *ura3* mutant background. A KanMx expression cassette was included to ensure plasmid maintenance during the tests. In wild-type cells, where the *DAN1* gene is normally silent, cells were not able to grow on geneticin-containing plates without uracil (SD-ura), but were able to grow on geneticin-containing plates containing uracil and 5-fluoroorotic acid (5-FOA), which requires Ura3p to be converted into a toxic compound. The opposite growth results were found with *erg3* , where *DAN1* is expressed under aerobic conditions ([Figure 1](#F1){ref-type="fig"}). To select mutants that are defective in the *erg3*-dependent induction of *DAN1*, we mutagenized *erg3 ura3* cells harboring the DAN1-URA3 plasmid with ethanemethanesulfonate, allowed the cells to recover from the mutagenesis, and then selected for cells that grew on geneticin containing 5-FOA plates (thus defective for *DAN1* induction). Cells were then cured of the plasmid and retransformed with plasmids containing β-galactosidase (lacz) under control of the *DAN1* or *ERG28* promoters. Mutants that reduced the expression of β-galactosidase from both promoters when compared with the parental strain were backcrossed twice, and mutants showing a 2:2 segregation were selected. Two mutants with strong and consistent phenotypes were chosen for further analysis. Genomic DNA was isolated and sequenced from two mutant and wild-type segregants and SNPs in common among the mutants were identified. This procedure identified candidate transition mutations, expected by ethanemethanesulfonate mutagenesis, in each mutant strain. In one mutant, the *SPT7* gene harbored a G to A transition leading to a stop codon at amino acid 814 (of 1332 aa) of the protein. In the other mutant, the *HFI1* gene carried a C to T transition leading to a stop codon at amino acid 55 (of 488 aa) of the protein. The *SPT7* and *HFI1* genes encode central components required for the integrity of the SAGA complex, a transcriptional activator of gene expression ([@B62]). Both stop codon mutants strongly affect induction of the *DAN1* and *ERG28* genes in the *erg3* mutant. β-Galactosidase activity was increased 78- and 16.5-fold in the *erg3* mutant for the *DAN1* and *ERG28* driven constructs respectively, whereas the corresponding increases when combined with the *hfi1-1* or *spt7-1* mutations were much lower ([Table 1](#T1){ref-type="table"}). To verify these results, we created complete gene disruptions of the *HFI1* and *SPT7* genes in the wild-type and *erg3* backgrounds and analyzed the expression of *DAN1* and *ERG28* by quantitative PCR. These results confirmed that these SAGA complex subunits are required for the increased gene expression of *DAN1* and *ERG28* in the *erg3* mutant ([Figure 2](#F2){ref-type="fig"}). In wild-type cells, there are no effects of SAGA mutations on the expression of the *DAN1* gene, but the *ERG28* transcripts are reduced ∼50%. In the *erg3* mutant the SAGA mutations reduce the *ERG28* transcripts to wild-type levels, suggesting a particular role of the SAGA complex in regulating gene expression under sterol deficiency. Furthermore, the induction of several other erg and anaerobic genes in the *erg3* mutant is affected by *spt7* and *hfi1* deletion (Supplemental Figure 1). On the other hand, four of seven ergosterol synthesis genes were unaffected by the SAGA mutations in the wild-type background, suggesting a specific role for the SAGA complex in the mechanism of increased expression in the *erg3* mutant.

![Test of selection strategy for mutants unable to induce anaerobic genes. (A) Gene fusion of the *DAN1* promoter with the ORF of *URA3*. (B) Cells were prepared and 10-fold dilutions were spotted onto SD plates without uracil or with uracil and 5-FOA. A representative example is shown. The selection for mutant isolation required the mutated *erg3 ura3* strain to grow on 5-FOA.](2637fig1){#F1}

###### 

Quantification of β-galactosidase activity from cells with lacZ controlled by the *DAN1* or *ERG28* promoter in wild type, *erg3*, and the backcrossed point mutants, *spt7-1* and *hfi1-1*, in the *erg3* background.

  Strain          *DAN1*-lacZ   *ERG28*-lacZ
  --------------- ------------- --------------
  Wild type       0.3           28.3
  *erg3*          23.5          464.8
  *erg3 spt7-1*   1.8           80
  *erg3 hfi1-1*   2.8           152

Representative data from one experiment are shown.

![Effects of *spt7*Δ and *hfi1*Δ mutations on expression of the anaerobic gene *DAN1* and the ergosterol biosynthesis gene *ERG28* in wild-type and *erg3* mutant backgrounds. Cells were grown in rich medium to early log phase, and RNA was extracted and quantified by qPCR. The *hfi1* and *spt7* mutations strongly reduce the *erg3*-dependent gene induction. The results are averaged from three experiments. The data from the *hfi1* and *spt7* mutants were compared pairwise with the wild type and *erg3* mutants by a *T* test. The *p* value was always \<1.25 × 10^−4^.](2637fig2){#F2}

Relocation of the SAGA complex in the *erg3* mutant
---------------------------------------------------

The positive function of the SAGA complex that has been revealed in the *erg3* mutant suggests that the complex is working on a specific set of genes when sterol composition is altered. To probe the localization and interaction partners of the SAGA complex in wild-type and *erg3* mutant cells we amplified tandem affinity purification (TAP)-tagged *SPT7* and *HFI1* genes ([@B20]) by PCR and introduced them into our wild-type and *erg3* mutant strains in place of the wild-type genes. The TAP-tagged complex was isolated from wild-type and *erg3* mutant cells using a one-step purification ([@B41]), and the proteins were analyzed by SDS--PAGE and silver staining ([Figure 3](#F3){ref-type="fig"}). The subunit composition of the complex from both wild-type and *erg3* mutant cells resembles that found previously ([@B62]; [@B55]), and only minor differences are seen whether the complex was purified using the SPT7-TAP or HFI1-TAP tags. Furthermore, no obvious differences were seen when comparing the complexes purified from wild-type and *erg3* mutant strains, suggesting that major differences in subunit composition cannot explain a specific role of the SAGA complex in the *erg3* mutant.

![Purification of the SAGA complex from wild type and *erg3* mutants. Wild-type or *erg3* strains with SPT7 or HFI1 tagged with TAP were purified in a single step and analyzed by SDS--PAGE and silver staining. Control purifications from untagged strains are also shown. The subunit composition looks similar after purification with either tag or from either TAP tagged strain. Bands were identified by comparison with published results ([@B55]). A single representative example is shown from at least three experiments.](2637fig3){#F3}

To investigate the positioning of the SAGA complex on the yeast chromosome in the wild-type and *erg3* mutant cells, we performed chromatin immunoprecipitation sequencing experiments (ChIP-Seq; [@B29]) using our TAP-tagged *HFI1* and *SPT7* constructs (see *Materials and Methods* for details). Cells were cross-linked with formaldehyde, harvested, and disrupted with lysis buffer using zirconium/silica beads. After shearing, complexes were isolated using rabbit immunoglobulin G (IgG)-coupled magnetic beads from precleared extracts and washed before de-cross-linking and DNA purification. DNA sequences were obtained, and sequence reads were analyzed. The overall analysis of the results shows that the correlation between promoter recoveries is very high whether the ChIP-Seq experiment was done using HFI1-TAP or SPT7-TAP in either wild-type or *erg3* cells, demonstrating the high quality of the data. The correlation scatter plot ([Figure 4](#F4){ref-type="fig"}) also shows a good correlation when comparing promoter recoveries from wild-type and *erg3* cells; however, there is a conspicuous broadening of the scatter plot with an increase in recoveries of certain promoters in *erg3* cells. This suggests that mostly the same sites are occupied by the SAGA complex in the wild type and *erg3* mutant but that some promoters seem to be recovered more efficiently in the *erg3* mutant. To obtain a more general impression of the changes of SAGA complex promoter occupancy induced by the changes in sterol structures, we ranked the promoter sequences by their fold enrichment in the *erg3* mutant compared with the wild type after IP with the SPT7-TAP construct (complete results in Supplemental Table 2). Among the top 32 hits, which represents ∼ 0.5% of the genome, we found four genes that are specifically expressed under anaerobic conditions and 10 genes involved in ergosterol biosynthesis, resulting in an astounding 87-fold enrichment for genes annotated (Gene Ontology) in the ergosterol biosynthesis pathway and a 188-fold enrichment for genes with an expression profile similar to that of *DAN1* (20 genes total, as found on the Saccharomyces Genome Database; <http://spell.yeastgenome.org/search/show_results?search_string>=YJR150C).

![Overview of ChIP-Seq results. ChIP-Seq experiments were performed on wild-type or *erg3* strains using either TAP-tagged *HFI1* or *SPT7*. Each dot represents one promoter, and the value (in log scale) is the quantification of ChIP-seq signal at that promoter. Global correlations between conditions (TAP tag or the yeast strain) are indicated. ChIP-Seq results are highly correlated when different tags are used in either wild-type or *erg3* mutant cells. The correlation is less tight when comparing the results with the same Tag in wild type vs. *erg3* mutants, indicating a change in promoter occupancy. The ChIP-Seq experiment was performed once.](2637fig4){#F4}

To visualize better and compare the enrichments seen by ChIP-Seq with the increases in transcript levels seen previously ([@B25]), we compared their enrichment using a scatter plot ([Figure 5](#F5){ref-type="fig"}). There is a striking enrichment of anaerobic genes (green circles) and ergosterol metabolism genes (blue rectangles) among the genes showing coenrichment (red dots). One of these genes (*HES1*) is involved in ergosterol metabolism and is expressed under anaerobic conditions. These data provide additional evidence for the highly specific effect on transcription, correlated with chromosome positioning, exerted by the SAGA complex on these two sets of genes. Therefore we conclude that the SAGA complex responds to changes in sterol composition by increasing its occupancy of promoters of anaerobic and *erg* genes and this seems to reflect a broad change in behavior to coordinate the new pattern of gene expression.

![Comparison of the ChIP-Seq and microarray experiments all genes. ChIP-seq results were quantified in the wild-type and *erg3* mutant strains using either the SPT7-TAP or HFI1-TAP. Promoter recovery from the *erg3* mutant divided by the recovery from the wild type is shown on the *x*-axis. The fold increase of transcript levels in *erg3* over the wild type is shown on the *y*-axis. Genes involved in ergosterol metabolism (blue rectangles) and whose expression is increased under anaerobic conditions (green circles) are highlighted. *HES1* is expressed under anaerobic conditions but is a member of the oxysterol-binding family of proteins ([@B32]), proposed to be involved in transfer of sterols between membranes ([@B11]).](2637fig5){#F5}

Changes in proteins associated with the SAGA complex in the *erg3* mutant
-------------------------------------------------------------------------

[Figure 3](#F3){ref-type="fig"} demonstrates that the basic subunit composition of the SAGA complex probably does not change between the wild type and the *erg3* mutant. However, as the SAGA complex is abundant and localizes at many chromosomal locations, it is likely that many recruited factors could be present in substoichiometric amounts and/or bind to the complex with low affinity. Therefore we sought to characterize the SAGA complexes in the wild type and the *erg3* mutant by using sensitive semiquantitative proteomics. The complex was purified from the wild-type and *erg3* strains using the Spt7-TAP tag, and then the relative signals for the recovered proteins were determined. The complete results are shown in Supplemental Table 3. A total of 208 proteins were detected in duplicate experiments. In the two experiments, 52 and 31 proteins were recovered two times more efficiently in the SAGA complex purified from the *erg3* mutant. More proteins, 69 and 49, were enriched at least 1.5-fold. The subunits of the SAGA complex were robustly detected from both wild-type and *erg3* mutant strains. The apparent signals were similar from the wild type and the *erg3* mutant, and while there was some variation in the detection of the different subunits, the signal was relatively similar and strong. Therefore we conclude that the basic subunit composition was not changed, consistent with the analysis by SDS--PAGE. Next we focused on weaker signals that either were found only with complex isolated from the *erg3* mutant or whose signal was greater than double that found with complex isolated from the wild type. Among the proteins preferentially associated with the SAGA complex in the *erg3* mutant, we found eight subunits, Snf5p, Snf6p, Snf12p, Swp82p, Arp5p, Arp7p, Tri1p, and Taf14p, associated with the SWI/SNF chromatin remodeling complex. Subunits of this complex were approximately twofold more enriched in the complex purified from *erg3* cells. This complex has been shown to interact functionally with the SAGA complex and is responsive to hypoxia in yeast and animal systems ([@B40]; [@B49]; [@B6]; [@B36]; [@B9]). It has been proposed that histone acetylation by the SAGA complex predisposes the SWI/SNF complex to displace nucleosomes from promoters, thus allowing an increase in transcription. We also identified several known transcription factors, including Pdr1p, Skn7p, Upc2p, and Hap1p, some of which were detected only in the purification from *erg3* cells, as well as several other proteins, including Rvs167p (see below), a protein involved in endocytosis ([@B47]). [Table 2](#T2){ref-type="table"} shows the relative recovery of some of these proteins as determined by semiquantitative proteomics. Spt3p, a component of the SAGA complex, is included in this table for reference.

###### 

Enrichment of proteins with the SAGA complex from the *erg3* mutant.

  Gene       Expt 1 *erg3*/wt   Expt 2 *erg3*/wt
  ---------- ------------------ ------------------
  *ARP7*     2.20               1.49
  *SNF5*     2.92               1.79
  *HAP1*     13.21              3.82
  *PDR1*     Infinite           Infinite
  *SKN7*     Infinite           Infinite
  *UPC2*     7.67               Infinite
  *RVS167*   Infinite           Infinite
  *SPT3*     1.29               1.12

The SPT7-TAP tagged SAGA complex was purified from wild type and *erg3* mutants and analyzed by semiquantitative proteomics. The relative signals of two subunits of the SWI/SNF complex (Arp7p, Snf5p), transcription factors (Hap1p, Pdr1p, Skn7p, Upc2), Rvs167p, and a SAGA complex subunit (Spt3p) are shown. Two independent experiments were analyzed with duplicate measurements (average is shown).

Next we concentrated on the roles of the four transcription factors because Upc2p and Hap1p have been implicated in regulating sterol biosynthesis and response to oxygen ([@B8]; [@B42]; [@B1]; [@B58]). We constructed mutants of the transcription factors in the *erg3* mutant strain and tested their effects on mRNA levels for anaerobic and ergosterol gene expression by quantitative PCR ([Figure 6](#F6){ref-type="fig"}). The *upc2* mutation abrogates completely the induction of the anaerobic gene *DAN1* in the *erg3* mutant but had only a partial effect (∼50%) on induction of the *ERG28* gene. The *hap1* mutation decreased induction of *DAN1* by 30%, and *ERG28* by 35%, which is much less than SAGA mutants. The *pdr1* mutant slightly reduced *DAN1* expression but had no effect on *ERG28*, and the *skn7* mutant increased expression of both *DAN1* and *ERG28* genes. In contrast, the SAGA mutants, *hfi1* and *spt7*, completely blocked the induction of *ERG28*. The effect was also very strong (\>85%) on *DAN1*, but somewhat less than *upc2*, although the biological significance of these small differences is difficult to assess. These data confirm the crucial role of Upc2p in anaerobic gene expression, but also that control of ergosterol genes is more complex and not solely dependent on a single transcription factor. Consistent with this, the transcription factor mutations, *upc2* and *hap1*, lowered, but did not completely block, the induction of *ERG28* in the *erg3* mutant. This could be explained if the recruitment of multiple transcription factors to *erg* gene promoters by the SAGA complex is required for their induction. This points to a role of the SAGA complex in coordinating the transcriptional response to changes in ergosterol, most likely through interaction with transcription factors and via chromatin remodeling, its known functions. To see whether the role of the SAGA complex might be broader than the control of anaerobic and ergosterol genes, we tested two other pathways whose transcription was induced in the *erg3* mutant, stress and basic amino acid synthesis ([@B25]). As a marker of the stress pathway we used *HSP42*, encoding a small heat shock protein that responds to different stresses ([@B24]; [@B28]; [@B59]), and *ARG3*, encoding ornithine carbamoyltransferase ([@B45]). The induction of *HSP42* in the *erg3* mutant is completely abrogated by SAGA mutations, and the *erg3*-dependent increase was reduced by ∼50% by deletion of the transcription factors *PDR1* or *SKN7*, but unaffected by deletion of *HAP1* and even increased by deletion of *UPC2*. For the *ARG3* gene, only the *pdr1* mutation has a small, but significant, effect, even though the SAGA complex mutations reduced the expression to wild-type levels in the *erg3* mutant. These results are consistent with the copurification of these transcription factors with the SAGA complex from the *erg3* mutant and support a broad role of the SAGA complex in orchestrating the change in transcriptional profile in response to changes in ergosterol, most likely through a combination of mechanisms including positioning on the chromosome, acting as a coactivator of transcription and as a chromatin modifier.

![qPCR quantitation of mRNA levels in SAGA and transcription factor mutants. mRNA levels of *DAN1*, *ERG28*, *HSP42*, and *ARG3* were determined by qPCR in wild type, *erg3*, and *erg3* double mutants. Mutations in the SAGA complex reduce *erg3*-dependent induction to wild-type levels for all genes probed. The only other double mutant to completely reduce the *erg3*-dependent induction to wild-type levels is *erg3 upc2* for the anaerobic gene, *DAN1*. The averages are from triplicate experiments. The data from all double mutants were compared pairwise with those of the *erg3* mutant. Results that were not significantly different are labeled (ns). All other *p* values were \<4 × 10^−2^.](2637fig6){#F6}

Moonlighting function of Rvs167p
--------------------------------

A prominent protein that was coisolated with the SAGA complex from the *erg3* mutant, but not detected in the proteomics experiment from wild type, is Rvs167p. *RVS167* was first identified in a screen for reduced viability upon starvation ([@B12]) and was subsequently shown to be suppressed by mutations in sphingolipid biosynthesis ([@B56]) and to play a role in the internalization step of endocytosis and actin organization ([@B47]; [@B34]). Rvs167p can be found associated with Rvs161p, and the two have been proposed to function together in endocytosis ([@B43]). Rvs167p has a BAR domain ([@B2]), which has been suggested to play a role in membrane constriction during endocytosis ([@B48]). Like other BAR domains, the Rvs167p BAR domain interacts with membranes in a curvature-dependent manner, and mutations affecting lipid composition can affect its interaction with actin cortical patches involved in endocytosis ([@B64]). Rvs167p has been identified in a systematic screen as a lipid-binding protein ([@B17]). As the described function and localization of Rvs167p is at the plasma membrane, we were surprised to find it associated with the SAGA complex, especially as its peptides were identified with similar efficiency as for the transcription factors described above despite not being more abundant in cells. However, Rvs167p was recently identified as a probable cargo of the nuclear export factor, Crm1p ([@B38]), implying that it transits through the nucleus. To provide additional evidence to support the proteomics results, we isolated the Spt7-TAP tagged SAGA complex and assayed for the presence of the Rvs161 and Rvs167 proteins in the purified fraction by Western blotting ([Figure 7](#F7){ref-type="fig"}). The specificity of the antisera was confirmed by comparing wild-type and the relevant *rvs161* or *rvs167* deletion strains. The expected size and an additional slower migrating band were detected for Rvs167p, the latter potentially corresponding to a ubiquitinated form ([@B57]). In two separate experiments we could confirm the coisolation of Rvs167p with the SAGA complex in *erg3* cells, whereas Rvs161p was not found. However, using this method we could also detect the Rvs167 protein, albeit less abundantly, associated with SAGA complex isolated from wild-type cells. This confirms association of Rvs167p with the SAGA complex and its increase in the *erg3* mutant found from the proteomics data and is consistent with a possible function of Rvs167p that is independent of Rvs161p.

![Copurification of Rvs167p with the SAGA complex. Total cell extracts were prepared from *erg3*, *rvs161*Δ, and *rvs167*Δ cells and separated by SDS--PAGE and processed for Western blotting to validate the antisera. The SAGA complex was purified using a one-step procedure based on the TAP tag from wild-type or *erg3* cells with (IP with SAGA) or without (Mock) TAP-tagged *SPT7*. The purified proteins were separated by SDS--PAGE and analyzed by Western blotting. The results from two independent experiments are shown.](2637fig7){#F7}

To determine the localization of Rvs167p in wild-type and *erg3* mutant cells, we created strains with chromosomally tagged Rvs167-GFP (green fluorescent protein) and Spt7-mCherry, as a marker for the nucleus. As expected, SPT7-mCherry clearly marked the nucleus in both wild-type and *erg3* mutant cells. Also as expected, Rvs167-GFP could be seen in punctate spots at the plasma membrane in wild-type and *erg3* mutant cells, as well as a diffuse staining throughout the cells. The punctate localization of Rvs167-GFP is strongly reduced in *erg3* cells ([Figure 8A](#F8){ref-type="fig"}) as quantified using Cell Profiler ([Figure 8B](#F8){ref-type="fig"}) and corrected by removal of the background fluorescence determined by using cells not expressing Rvs167-GFP (see Supplemental Figure 2). Interestingly, the alpha factor internalization profiles of the *erg2* mutant and the *rvs167* mutants are similar at 24°C, characterized by a slower rate of uptake and a reduced plateau ([@B47], [@B46]), suggesting that the endocytic phenotype seen in the *erg2* mutant under these conditions might be due to a reduction of the Rvs167p localized in the punctate dots at the plasma membrane in the absence of ergosterol.

![Localization and role of Rvs167p in *erg3*-dependent gene induction of *HSP42* and *HSP104*. (A) RVS167-EGFP and SPT7-mCherry were visualized in wild-type and *erg3* mutant cells. Raw data, two deconvoluted images, and deconvoluted merged images are shown. Puncta of RVS167-EGFP are clearly less intense in the *erg3* mutant. The arrows points to cells with a strong Spt7-mCherry signal indicating a focus plane on the nucleus. One can see the corresponding RVS167-EGFP signal in the nucleus in the adjacent panel. (B) Cells were segmented into puncta, cytoplasm, and nucleus (overlap with SPT7-mCherry) and quantified as described after background subtraction (Supplemental Figure 2) for the EGFP signal. The nucleus/cytoplasm ratio of the EGFP intensity is shown. No error bars are shown for the top panel because they would not be seen anyway. The *p* values from a *T* test are shown. (C) mRNA levels in wild type, *erg3*, *erg3 rvs167*, and *erg3 rvs161* were quantified by qPCR, and the mRNA levels were divided by the wild-type levels. Mutation of *rvs167* abrogated the *erg3*-dependent induction of *HSP42* and *HSP104*, but not the other genes. The data are from triplicate experiments. The data from all double mutants were compared pairwise with the *erg3* mutant. Results that were not significantly different are labeled (ns). All other *p* values were \<5 × 10^−3^.](2637fig8){#F8}

The total Rvs167-GFP signal in the cytoplasm was greater than elsewhere, and its intensity was significantly higher over the nucleus and cytoplasm in *erg3* mutant cells. This difference can be seen by visual inspection of the deconvoluted slices with a focus on the SPT7-mCherry signal ([Figure 8A](#F8){ref-type="fig"}, arrows) and by quantitative assessment. The intensity of the Rvs167p signal over the nucleus is ∼80% of the intensity over the cytoplasm, and this percentage is significantly increased in the *erg3* mutant ([Figure 8B](#F8){ref-type="fig"}). Although the amounts of Rvs167-GFP are low in the nucleus, the amounts present are consistent with its coisolation with the SAGA complex as detected by proteomics and Western blotting. It is possible that this small difference in the amount of nuclear localization can explain the increased amount isolated with the SAGA complex from *erg3* mutant cells. Because the finding of Rvs167p in the nucleus is consistent with its purification with the SAGA complex, we next tested whether its deletion can affect gene induction in the *erg3* mutant. As control for a defect in endocytosis we also deleted *RVS161*, which works with Rvs167p for endocytosis but which was not found in our SAGA purification. As can be seen ([Figure 8C](#F8){ref-type="fig"}), *RVS167* deletion specifically abrogated the induction of *HSP42* and *HSP104* but had no effect on the expression of the other genes tested. This is not due to an endocytic phenotype because *RVS161* was not required for induction of any of these genes in the *erg3* mutant. Deletion of *RVS161* caused an increase in *DAN1* and *ERG28* transcripts. We do not have an explanation for this finding, but these changes are in the opposite direction from that seen with *RVS167*. The localization, copurification with SAGA, and effects on transcription suggest a novel function for Rvs167p, which is independent of its associated homologous partner, which lacks the BAR domain.

DISCUSSION
==========

The main finding of this study is that the SAGA complex plays a crucial role in carrying out a wide range of specific changes in the transcriptional profile in response to changes in sterol composition in the *erg3* mutant. This conclusion is based on genetic evidence as well as experiments examining the physical location and interactions of this complex in wild-type and *erg3* cells. These results suggest that the SAGA complex acts as a coactivator of transcription for ergosterol and anaerobic genes, as well as other gene classes, such as basic amino acid synthesis and stress response. Deletion of the SAGA complex affects the expression of only some of these genes in wild-type cells; however, the effects of its deletion are much stronger in the *erg3* mutant and are seemingly commensurate with the size of the increase caused by the sterol deficiency. Therefore it seems that the proportional role of the SAGA complex in the expression of anaerobic genes and *erg* genes increases in the *erg3* mutant.

The SAGA complex seems to coordinate the increased expression of other sets of genes, including those for basic amino acids and some involved in stress. It is a coactivator of transcription that is postulated to connect the preinitiation complex with epigenetic chromatin modifications. It has several chromatin modification activities, including a histone acetyltransferase and deubiquitination modules that map to distinct parts of the complex ([@B13]). SAGA-acetylated nucleosomes have been shown to be displaced by the SWI/SNF complex ([@B6]). Indeed, we found an increased association of SWI/SNF complex proteins with the isolated SAGA complex (twofold) from the *erg3* mutant, suggesting an increased transcriptional activity where these proteins interact. This is one possible mechanism to increase transcription without necessarily increasing transcription factor association or changing the location of the complex on the chromosome. This sort of mechanism could be important for the SAGA-dependent induction of genes for which we did not detect an increased promoter occupancy or identify an increase in recruitment of specific transcription factors.

For many Erg and anaerobic genes, the SAGA complex seems to be enriched on their promoters in the *erg3* mutant compared with wild-type cells and is associated with transcription factors involved in their regulation. For anaerobic gene induction, transcription factor recruitment could play a key and direct role in the *erg3* mutant. Deletion of *UPC2* completely blocked anaerobic gene expression, and it could be responsible for recruitment of the SAGA complex for this regulation. Upc2p has been shown to bind sterol, and in the absence of sterols it moves from the cytoplasm to the nucleus ([@B63]), it can bind to anaerobic gene promoters and, we propose, recruit the SAGA complex. Although unexplored for the moment, it is likely that the sterol produced in the *erg3* mutant, lacking the Δ5 double bond, does not bind Upc2p with high affinity. On the other hand, this mechanism alone cannot explain the increase in Erg gene expression, because even in the absence of Upc2p, the *ERG28* gene was still partially induced in response to sterol alteration. Therefore Upc2p relocation to the nucleus in response to sterol changes is not absolutely required for *ERG28* gene induction, which we assume is an indicator for other ergosterol biosynthesis genes that behave similarly in transcript profile and SAGA occupancy. It is possible that multiple transcription factors regulate the ergosterol biosynthesis genes and elimination of just one of these, or their regulation, does not abrogate SAGA recruitment and function.

In the case of genes involved in basic amino acid synthesis, we found a small increase in the presence of the SAGA complex on their promoters, but we did not identify any transcription factors involved in their regulation ([@B52]; [@B54]) by our copurification experiments. For the stress genes, *HSP42* and *HSP104*, we did not find any consistent *erg3*-specific enrichment in SAGA localization over the promoter, but we did identify two transcription factors required for their regulation, Pdr1p and Skn7p, that are enriched with the SAGA complex under sterol deficiency. Among the other heat shock promoters, some showed an increased SAGA localization over their promoters, while others did not (Supplemental Table 2). It is possible that the amount of SAGA on some heat shock promoters in wild-type cells is already sufficient to regulate their genes and no increase in *erg3* mutants would be necessary. The change in regulation could be carried out through interaction with transcription factors.

In surprising results, we discovered that Rvs167p, which has previously been shown to play a direct role in the internalization step of endocytosis, associates with the SAGA complex, detected only in the *erg3* mutant, and is required for the *erg3*-dependent increase in *HSP42* and *HSP104* mRNA expression. It seems that these three factors, Rvs167p, Pdr1p, and Skn7p, work together with the SAGA complex to regulate the increase in transcription under sterol deficiency. These two heat shock proteins are involved in preventing and reversing protein aggregation and thus have a common function ([@B5]), consistent with a physiological coregulation through Rvs167p. Furthermore, both *HSP42* and *HSP104* show increased mRNA under carbon ([@B3]) and nitrogen ([@B19]) starvation, conditions under which the *rvs167* mutant shows reduced viability. Several proteins involved in endocytosis have been shown to play additional roles in nuclear signaling and transcription in animal cells and tissues ([@B51]). In particular, Bin1/amphiphysin II, a potential orthologue of Rvs167p, has been shown to functionally interact with Myc ([@B14]). Rvs167p interacts structurally and functionally with Rvs161p for its endocytic function ([@B43]), and the stabilities of the two proteins are interdependent, but not symmetrical. Deletion of *RVS167* destabilizes Rvs161p much more than deletion of *RVS161* destabilizes Rvs167p. This would be consistent with the moonlighting function of Rvs167p and suggests that the latter is probably stabilized by homotypic assembly or binding to another protein involved in the SAGA-dependent regulation of the *HSP42* and *HSP104* genes.

As the results with Rvs167p were unexpected, we performed control experiments that showed that the protein localization changes in the *erg3* mutant when compared with wild type. It was less associated with punctate dots at the plasma membrane and higher in cytosol and nucleus. It is possible that the entry of Rvs167p into the nucleus is passive. The molecular weight cutoff for diffusion across the nuclear pore has been suggested to be ∼60 kDa ([@B65]), but this would depend on the shape of the molecule. Rvs167p is below this limit (53 kDa), but when fused to GFP would be above this value (80 kDa), so the amounts of the fusion protein that we saw over the nucleus could be an underestimate. By Western blotting, where we detected the native protein, we detected a robust signal copurifying with the SAGA complex. In any event, it seems that the concentration of Rvs167p in the nucleus is slightly, but significantly, higher in the *erg3* mutant. The function of Rvs167p in the nucleus is not an indirect consequence of the block in the endocytic pathway because the *rvs161* mutant, which has the same endocytic phenotype as *rvs167*, did not block the *erg3*-­dependent induction of *HSP42* and *HSP104*. Furthermore, the finding, in a screening, that Rvs167p is a direct or indirect cargo of Crm1p (cargo B; [@B38]) can now be interpreted in functional context.

The SAGA complex clearly plays a central role in translating the sterol deficiency into a new pattern of transcription. From our data it seems that several different mechanisms are likely to play a role in this process. This is not surprising given the structural complexity of the SAGA complex and its complex interactions in the cell. In some cases, an increase in promoter occupancy by the SAGA complex seems to correlate with the increase in transcription. This is clearly the case for many genes involved in the anaerobic pathway and ergosterol biosynthesis. However, for other transcriptional activation pathways, different mechanisms must exist. Among these could be enhanced interaction with transcription factors or other factors, for instance, RVS167p, an increased interaction with the SWI/SNF complex, or epigenetic changes carried out by the SAGA complex.

The regulation of these mechanisms by ergosterol structure and quantities is still a mystery. Our selection for mutants that would interrupt the coregulation of anaerobic genes and ergosterol genes was designed to find genes that are required for sterol sensing and its connections to transcription. However, there is no direct evidence that the SAGA complex directly binds sterols. We propose that there is not a single sensor for sterols in the cells, but multiple ones, probably with some overlapping function. One of these sensors is likely to be Upc2p, but it can only fully account for the signaling to the pathway for induction of the anaerobic genes. In this model, the SAGA complex would be the sought-after cotranscriptional activator for Upc2p, which would help explain its function in transcription. Upc2p did not have an easily predictable binding site for sterols, so it is quite possible that several new sterol-binding proteins acting in this pathway can be found. Now that we have identified some players in the mechanism changing the transcriptional profile under ergosterol, it should be possible to decipher other mechanisms for sterol sensing and their connections to the SAGA complex.

MATERIALS AND METHODS
=====================

Plasmid construction
--------------------

pFA6a-pDAN1-lacZ-kanMX3-CEN/ARS was derived from pFA6a- lacZ-kanMX3 ([@B61]). The pRS416 CEN/ARS sequence was amplified by PCR and introduced into pFA6a- lacZ-kanMX3 at the *Eco*RI/*Spe*I sites of the polylinker, in order to use this plasmid for yeast transformation. Of the *DAN1* promoter (pDAN1), 800 base pairs was amplified by PCR and subcloned into pFA6a-lacZ-kanMX3-CEN/ARS at the *Bam*HI/*Pac*I sites of the polylinker, just in front of the lacZ-kanMX3 cassette, introducing an ATG at the *Pac*I site. For pFA6a-pERG28-lacZ-kanMX3-CEN/ARS, a similar construct using 500 base pairs of the promoter region of *ERG28* gene was used. For pFA6a-pDAN1-URA3-kanMX3-CEN/ARS and pFA6a-pERG28-URA3-kanMX3-CEN/ARS the lacZ region was replaced by *URA3*, amplified by PCR from the pRS416 (URA) plasmid. *URA3* was subcloned using *Pac*I/*Asc*I in order to keep the ADH terminator after URA3. To create pFA6a-pDAN1-URA3-hphMX3-CEN/ARS and pFA6a-pERG28-URA3-hphMX3-CEN/ARS we exchanged the kanMX cassette with the hygromycin (hphMX3) cassette from plasmid pAG34 using *Bgl*II/*Pme*I restriction enzymes. The plasmids used in this study are listed in Supplemental Table 4.

Yeast media and gene deletion
-----------------------------

Yeast strains were routinely grown in YPUAD medium (2% glucose \[Merck, Darmstadt, Germany\], 2% Bacto Peptone \[Difco, Allschwil, Switzerland\], 1% yeast extract \[Difco\], 10 mM 2-(*N*-morpholino)ethanesulfonic acid \[Sigma-Aldrich, Steinheim, Germany\], 40 mg/l [l]{.smallcaps}-tryptophan \[Sigma-Aldrich\], uracil \[Sigma-Aldrich\], and adenine (\[Sigma-Aldrich\]) to early log phase, except for mutant selection. The deletion strains were generated by replacing the genomic copy by the selectable kanMX6 or loxP-kanMX-loxP cassette in wt (RH 2879) and *erg3* strains (RH5702) or by disruption in an isogenic diploid and tetrad dissection. The gene deletion cassette was amplified by PCR from pFA6a-kanMX6 ([@B44]) or pUG6-loxP-kanMX-loxP ([@B26]) with the oligonucleotides of the genes to be deleted. The wild-type strain RH2879 was transformed with the lithium acetate method ([@B21]), and the *erg3* mutant strain RH5702 was transformed with a high-efficiency electroporation method. Briefly, 50 ml of cells was grown in YPUAD medium to 1--1.5 OD~600~ units. Cells were harvested by centrifugation and resuspended in 25 ml lithium acetate buffer (0.1 M LiAc, 10 mM dithiothreitol, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA) for 1 h. Cells were washed and resuspended in 200 µl of 1 M cold sorbitol, and 80 µl was used for electroporation. The electroporated cells were incubated in 2 M sorbitol/YPUAD for at least 3 h before plating on a selective geneticin plate. We found that electroporation techniques were the most efficient method for introducing DNA into the *erg3* mutant.

EMS treatment
-------------

The reporter construct for gene induction and selection, the pDAN1-URA3 plasmid (plasmid 3140), was introduced into the *erg3* strain, which was grown overnight, and 5 × 10^8^ cells were resuspended in 10 ml of 50 mM KPO~4~, pH 7.0. Chemical mutagenesis was carried out with 240 µl per 8 ml of culture of ethyl methanesulfonate (EMS) with gentle rotation on a shaker platform for 30 min at 30°C. Mutagenesis was stopped with 8 ml of 10% sodium thiosulfate. EMS-treated cells were split into 20 aliquots, grown overnight at 30°C, and plated onto 5-FOA + geneticin selective medium. After 3 d of growth on the selective medium, colonies were replica plated on YPUAD + geneticin to ensure that mutations were from plasmid loss. Six colonies were picked per aliquot and retransformed with the plasmids pDAN1-lacZ-hphMX (plasmid 3143) and pERG28-lacZ-hphMX (plasmid 3144), respectively, to control the mutation with a β-galactosidase assay. Mutants with a low β-galactosidase activity for both genes were selected. A quantitative real-time PCR (qPCR) quantification of *DAN1* and *ERG28* genes on the clones that had a resistance to 5-FOA and a reduced β-galactosidase activity was carried out, and the mutants were backcrossed twice to a wt strain.

Untreated cells and EMS-treated cells were plated on separate YPUAD plates to calculate the percentage survival of mutants using the equation (CFU treated plate/CFU untreated control) × 100, and the result was from 53%--68% survival. The percentage of mutation was from 2.5%--10% (CFU 5 --FOA + geneticin/CFU SD + all amino acids + geneticin), and the plasmid loss during the experiment was between 30 and 50%.

β-Galactosidase assay
---------------------

After introduction of pDAN1-lacZ (plasmid 3143) and pERG28-lacZ (plasmid 3144) into *erg3* EMS mutants the cells were grown overnight at 30°C and then aliquoted (300 µl) in a 96-well plate. The cells were centrifuged, washed, and resuspended in 100 µl of Z-buffer adapted from [@B37]; 60 mM Na~2~HPO~4~⋅7H~2~O, 40 mM NaH~2~PO~4~⋅H~2~O, 10 mM KCl, 1 mM MgSO~4~⋅7H~2~O, 50 mM β-mercaptoethanol, 0.2% sodium lauroylsarcosine). The cell density was measured at OD~720~ nm, and the cells were permeabilized at 30°C for 30 min. ONPG (orthonitrophenyl-β-galactoside; 25 µl of 4 mg/ml) was added and incubated for 60 min at 30°C. The reaction was stopped with 60 µl of 1 M Na~2~CO~3~, and orthonitrophenol liberation was quantified in the spectrophotometer at OD~420~ nm. The activity was converted into Miller units with the following conversion: (OD~420~ × 1000)/OD~720~ × culture volume (ml) × assay time (min).

RNA extraction and qPCR
-----------------------

Yeast strains were grown in triplicate to OD~600~ = 0.8--1. The cells (2 ml) were centrifuged, frozen in liquid nitrogen, and stored at --80°C. Total RNA extraction was performed using the RNeasy Mini Kit (Qiagen No: 74104) mechanical disruption protocol including a column DNase treatment. RNA quantity and purity was controlled using a spectrophotometer: ratios 260/280 (protein contamination) and 260/230 (guanidinium thiocyanate contamination) were greater than or equal to 2.0.

One microgram of RNA was used for cDNA synthesis using the Superscript II (Invitrogen) reverse transcription reaction with random hexamers. qPCR analysis was performed on a CFX Connect Real-Time PCR system using SsoAdvanced Universal SYBR Green supermix (Bio-Rad, Switzerland).

Primers were designed using the Primer3 program, and sequences are listed in Supplemental Table 4. The amplification profile for qPCR was 95°C, 1 min, followed by 40 amplification cycles at 95°C, 10 s, and 60°C, 30 s. The run was completed with the dissociation curve from the start at 65°C to 95°C with 0.5 increments. Standard curves were done for each specific gene target including the reference gene, and their efficiencies were all between 90 and 100%. Data analysis was done with the Bio-Rad CFX manager software version 3.1. Expression of the target gene was calculated relative to the wild-type condition after normalization to the reference gene *CDC73*. Triple biological replicates and triple technical replicates were analyzed.

High-throughput sequencing
--------------------------

Genomic DNA from two independent backcrossed EMS-generated yeast mutants were prepared using the Qiagen Genomic DNA kit No. 19060, including Qiagen proteinase K No. 19131 and Qiagen Genomic-tip 20/G No. 10223. DNA-seq libraries were prepared for sequencing using the Illumina PE-102-1002-Paired-end sequencing kit according to the manufacturer specifications. In brief, 2 µg of DNA was sonicated using the Covaris S2. After purification on the Qiagen column, fragmented DNA was end repaired and an adenosine overhang added to the 3′ ends. Paired-end Illumina adapters were ligated to the DNA. The eluted products were enriched using 18 cycles of amplification with Illumina PCR primers. Libraries were validated on the Bioanalyzer 2100 (Agilent) and Qubit fluorimeter (Invitrogen). Samples were loaded (at 8 pM loaded) on one lane of the Genome Analyser IIx from Illumina according to the single read--80 cycles sequencing protocol.

Yeast TAP-Tag and fluorescent protein strain construction
---------------------------------------------------------

The HFI1- and SPT7-TAP-Tagged constructs were amplified by PCR from a Tap-tag library ([@B20]) and then reintroduced into the RH2879 (wt) and RH6967 (*erg3*) strains. The primers used for SPT7-TAP-Tag cloning were SPT7-5′ (CCAGA­AGAAGACTTGGAAAACGACG), 260 base pairs before the SPT7 stop codon, and SPT7-3′ (TGTGATACCGAATTAACCCATGGG), 234 base pairs after the stop codon, and for HFI1-TAP-Tag the primers were HFI1-5′ (GGTTGAACCTTCAGGTTCATACTATGC), 201 base pairs before the HFI1 stop, and HFI1-3′ (AGGAATCATGCGAGACCCC), 278 base pairs after the stop codon.

EGFP or mCherry tags were respectively integrated chromosomally at the C-terminus of the *RVS167* and *SPT7* genes to create the RVS167-EGFP::HIS3MX6 and SPT7-mCherry::kanMX4 strains. The fluorescent protein tags were amplified by PCR using the plasmids pFA6a-EGFP-His3MX6, pFA6a-mCherry-KanMX4 (gift from Marko Kaksonen, Department of Biochemistry, NCCR Chemical Biology, University of Geneva) as described ([@B31]). The primers used are listed in Supplemental Table 4. Wild-type and mutant cells expressing EGFP or mCherry-tagged proteins had growth properties indistinguishable from those of untagged cells. Wild type (SPT7-mCherry) was crossed with *erg3* (RVS167-EGFP), and double fluorescent protein strains were generated by sporulation and tetrad dissection.

Live cell imaging
-----------------

Yeast cells were grown to logarithmic phase (OD~600~ = 0.5--0.7) in SC-Trp medium at 30°C, and 1 ml was harvested by centrifugation at 4000 × *g* for 1 min. The pellet was resuspended in 100 µl SC-Trp. The cells were attached to concanavalin A--coated coverslips (Sigma ConA-C2010:1 mg/ml). Cells (10 µl) were incubated for 6 min at room temperature on the concanavalin A--coated coverslips, then washed with SC-Trp medium, and imaged in 40 µl of SC-Trp medium. The pictures were taken at room temperature using an Olympus IX81 wide-field microscope equipped with a 100 × NA 1.45 objective.

For EGFP and mCherry fluorescence, 17 z stacks with 0.5 µm intervals and exposure time of 500 ms were imaged sequentially at each frame using a Hamatsu Orca-ER charge-coupled device camera. The microscope setup was controlled by Metamorph 7.5 software (Molecular Devices, Sunnyvale, CA). For bright field, we took a single image at 150 ms exposure.

A deconvolution program, Auto Quant X3 (Media Cybernetics), was applied to the pictures, and the best focus images of ∼1400 cells were analysed. Objects were identified and quantified by CellProfiler software ([@B35]) using the standard object identification module with Otsu's method of image thresholding. The accuracy of the automated segmentation of the nucleus and cell was confirmed by manual inspection. As a background control, we measured EGFP channel of cells expressing only mCherry fluorescence and we subtracted this value from our experimental data (see Supplemental Figure 2).

SAGA complex purification
-------------------------

Cells expressing a TAP-tagged (RH 7750, RH 7751, RH 7752, RH 7753) or untagged (RH2879, RH6867) SAGA complex protein, Hfi1p or Spt7p, were grown in 500 ml YPUAD to OD~600~ = 1.5. The cells were collected by centrifugation (10 min at 6500 × *g*, 4°C) and washed with 20 ml cold water, and the pellets were frozen at --80°C. The SAGA complex was purified by a single-step TAP Tag purification as described previously ([@B41]) with some modifications. Glass beads were used instead of zirconium/silica, and proteins were eluted with 0.5M NH~4~OH/0.5 mM EDTA, pH 10, to reduce the release of IgG. The eluate was neutralized and analyzed by an 8% SDS--PAGE gel and silver staining (ProteoSilver Plus Silver Satin Kit \[Sigma PROT-SIL\]) as well as by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS).

LC-MS/MS analysis
-----------------

For LC-MS/MS analysis, dried samples were resuspended in 6 M urea in 50 mM NH~4~HCO~3~, reduced with 10 mM Tris (2-carboxyethyl) phosphine hydrochloride for 30 min, and alkylated with 25 mM iodoacetamide for 30 min in the dark. Samples were diluted to 2 M urea with 50 mM NH~4~HCO~3~ and digested with trypsin (Promega; 1 μl of 0.5 μg/μl) in the presence of 1 mM CaCl~2~ for 12 h at 37°C. Peptides were acidified to a final concentration of 5% acetic acid, desalted over a self-packed C18 spin column, and dried. Peptides were analyzed by LC-MS/MS, and the MS data were processed with MaxQuant.

Peptides were resuspended in water with 0.1% formic acid (FA) and analyzed using Proxeon EASY-nLC 1000 nano-UHPLC coupled to QExactive Plus Quadrupole-Orbitrap mass spectrometer (Thermo Scientific). The chromatography column consisted of a 15 cm easy-spray column with 75 μm i.d. microcapillary, packed with 3 μm PepMap C18 particles (Thermo Scientific). LC solvents were 0.1% FA in H~2~O (Buffer A) and 0.1% FA in MeCN (Buffer B). Peptides were eluted into the mass spectrometer at a flow rate of 300 nl/min over a 240 min linear gradient (3--35% Buffer B) at 50°C. Data were acquired in data-dependent mode (top-20, NCE 30, R = 17′500) after full MS scan (R = 70,000, *m/z* 400-1300). Dynamic exclusion was set to 10s, peptide match to prefer, and isotope exclusion was enabled.

The MS data were analyzed with MaxQuant1 (V1.5.0.0) ([@B7]) and searched against the yeast proteome (UniProt, 6559 entries) and a common list of contaminants (included in MaxQuant). The first peptide search tolerance was set at 20 ppm, 7 ppm was used for the main peptide search, and fragment mass tolerance was set to 0.02 Da. The false discovery rate for peptides, proteins, and sites identification was set to 1%. The minimum peptide length was set to six amino acids, and peptide requantification and label-free quantification (MaxLFQ) were enabled. The minimal number of peptides per protein was set to two. Oxidized methionines and N-terminal acetylation and phosphorylation on serine, threonine, and tyrosine were searched as variable modifications. Carbamidomethylation of cysteines was searched as a fixed modification. Only proteins present in at least two replicates and with at least fourfold higher intensity over background were considered.

ChIP and analysis
-----------------

ChIP assays were performed as described previously ([@B29]) with the following modifications. IPs were performed with 60 µl rabbit (Sigma; I5006)-coupled magnetic Epoxy beads (Dynabeads M-270; Dynal Biotech, Invitrogen) and were quantified by qPCR using Sso Advance Universal SYBR Green Supermix on a CFX Connect Real-Time PCR machine (Bio-Rad, Switzerland). The IPs were normalized using the *GAL7* gene locus, and primers used and listed in Supplemental Table 4 were kindly provided by David Shore (University of Geneva). ChIP-Seq libraries were constructed from 5 ng of immunoprecipitated DNA according to the manufacturer's instructions (Illumina). Sequencing was done using 50 base pair single-end reads on the Illumina 2500 HiSeq system according to the manufacturer's specifications.

The mapping of the sequencing data was performed with Bowtie 2.1.0 in end-to-end mode, using the mapping module of the HTSstation analysis platform ([@B10]). Results can be downloaded (<http://htsstation.epfl.ch/mapseq/jobs/e9IBR9xqFdd7scDcgId5/get_results>).

For each condition (wt, wt-HFI1-TAP, wt-SPT7-TAP, *erg3*, *erg3*-HFI1-TAP, *erg3*-SPT7-TAP), genome-wide normalized read densities were calculated for forward and reverse-strand reads separately by counting the coverage at each position after cutting every read to the first 45 bases. This was then normalized by 10^−7^ times the total number of reads.

The normalized ChIP signal level was quantified by calculating the average in each gene promoter region (1 kb upstream to 100 base pairs downstream of every gene start as defined in the Ensembl database version 75 ([@B15])) using custom scripts (<http://bioscript.epfl.ch/>). Quantified signals in promoter regions were normalized by the median signal among all promoter regions in a given condition in order to compare results between the different conditions.

From the final table of signals, sorted by decreasing values of the signal ratio erg3-SPT7-TAP/erg3, we identified a set of genes of interest presented in [Table 2](#T2){ref-type="table"}.

Statistics
----------

All statistical data are represented using the SEM and were analyzed pairwise using the *t* test.
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ChIP

:   chromatin immunoprecipitation

EMS

:   ethanemethanesulfonate

5-FOA

:   5-fluoroorotic acid

IP

:   immunoprecipitation

LC-MS/MS

:   liquid chromatography, mass spectrometry with fragmentation

Seq

:   sequencing

TAP

:   tandem affinity purification

qPCR

:   quantitative PCR.
